WHO ICTRP trial
Comparison of nasal congestion difference post lefort surgery
IRCT20180312039060N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20180312039060N5 |
|---|---|
| Public title | Comparison of nasal congestion difference post lefort surgery |
| Scientific title | Comparison of nasal congestion difference post lefort surgery using mometasone furoate vs phenylephrine nasal spray |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Nasal congestion. |
| Interventions | Intervention 1: Patients will be randomly assigned to the intervention group (Mometasone Nasonex = Mometasone Furoate 0.05%, Organon). After surgery, each drug will be sprayed three times a day for 3 days in both sinuses, one puff… |
| Registration date | Dec 28, 2024 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: